Search for Clinical Trial Results
Biliary Atresia - 29 Studies Found
Status | Study |
Completed |
Study Name: A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy Condition: Biliary Atresia Date: 2006-02-21 Interventions:
|
Completed |
Study Name: Biliary Atresia, Hepatic Buffer Response and Sevoflurane Condition: Biliary Atresia Date: 2015-06-03 Interventions: Drug: Sevoflurane general anesthesia with 2% followed by 3% sevoflurane |
Recruiting |
Study Name: Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Condition:
Date: 2014-05-12 Interventions: Drug: Oral Vancomycin Oral Vancomycin is given to PSC or BA participants |
Completed |
Study Name: Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Condition:
Date: 2011-02-10 Interventions: Drug: Vancomycin Oral 50mg/Kg per day up to maximum of 1500 mg a day for three months. |
Completed |
Study Name: Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia Condition: Biliary Atresia, Kasai Portoenterostomy Status Date: 2014-11-19 Interventions: Drug: Meloxicam The intervention drug, meloxicam is safe medicine which is used to treat pain or inflamm |
Completed |
Study Name: The Comparison of Desflurane and Sevoflurane on Postoperative Recovery and Hepatic Function of Biliary Atresia Patients During Kasai Operation Condition:
Date: 2011-09-16 Interventions:
|
Recruiting |
Study Name: Biliary Atresia Research Consortium Condition:
Date: 2003-06-05 |
Not yet recruiting |
Study Name: Transfusion Strategies for Pediatric Liver Transplantation Condition: Biliary Atresia Intrahepatic Syndromic Form Date: 2016-10-25 Interventions:
|
Completed |
Study Name: the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia Condition: to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients. Date: 2016-07-26 |
Completed |
Study Name: Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease Condition:
|